5 January 2017 – Ithaca, NY – Zymtronix, developer of revolutionary enzyme immobilization technologies, today announced that the company will be attending Cambridge Health Institute’s 16th Annual Peptalk: The Protein Science Week, which will take place January 9th – 13th in San Diego. This event is one of the largest annual gatherings of protein science researchers in the world, attracting nearly 1300 experts from academia, biotech and Pharma.

At Peptalk: The Protein Science Week, Stéphane Corgié, Founder and CEO-CTO of Zymtronix, will be speaking at the Biocatalysis and Bio-based Chemical Production conference on January 9th from 11:45 - 12:15. The talk will be on ‘Biocatalysis with Immobilized Enzymes – Bringing Single Enzymes and Enzymes Systems to the Process Scale’. This conference tackles the latest advances in biocatalysis and synthetic biology in enzyme engineering.

“Zymtronix is honored to be attending and speaking at Peptalk: The Protein Science Week 2017,” said Stéphane Corgié, Founder and CEO-CTO, Zymtronix. “As leaders of the next wave of biocatalysis we’re passionate about this area and look forward to discussing our technology and discovering new successful partnerships.”

About Zymtronix

Zymtronix Catalytic Systems, Inc. (DBA Zymtronix, Inc.) is a life science company formed in 2013 as a spin-off out of Cornell University Research. The company provides many industries – pharmaceutical, chemical manufacturing, agriculture and safety testing – with cost-effective solutions to maximize performance and usability of enzymes in all applications. The founders, Stéphane Corgié, PhD (CEO-CTO) and Juan Diego Alonso JD-MBA (CFO) are joined by Dr. Joseph Marasco who leads the company’s business development efforts as Chief Business Officer of Pharmaceutical Operations.